Please login to the form below

Not currently logged in
Email:
Password:

Zoetis

This page shows the latest Zoetis news and features for those working in and with pharma, biotech and healthcare.

Pfizer mulling product sale to streamline ops; sources

Pfizer mulling product sale to streamline ops; sources

unit Zoetis to deal with accretion and dilution.

Latest news

More from news
Approximately 2 fully matching, plus 26 partially matching documents found.

Latest Intelligence

  • Pharma deals during November 2014 Pharma deals during November 2014

    form of Zoetis who this month acquired Abbott's animal health business for $255m. ... Bill Ackman, a Valeant investor, now owns 8.5% of Zoetis, which may pave the way for a potential deal.

  • Pharma deals during April 2014 Pharma deals during April 2014

    spot in terms of sales, second only to Zoetis.

  • Pharma deals during January 2014 Pharma deals during January 2014

    Several major pharma firms are deciding where to focus their business interests with Pfizer spinning out Zoetis for its animal health interests and Abbott doing the same for its pharma business,

  • Pharma deals during December 2012 Pharma deals during December 2012

    The next major event in the animal health deal calendar will probably be the IPO of Pfizer's animal health business (named in the IPO documents as Zoetis) which had 2011

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Random42 Scientific Communication

    Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for over 550 product launches for the world's leading pharmaceutical, biotechnology and medical companies and won over 150

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Lars Bruening
Shaping healthcare
Bayer’s Lars Bruening talks about moving to the UK as the market works its way through a series of seismic changes...
No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...

Infographics